Mucolipidosis II. szokatlan biokémiai paraméterekkel.

Translated title of the contribution: Mucolipidosis II with unusual biochemical parameters

Eva Morava, Paschke Eduard, Gábor Tóth, Matild Dobos, B. Melegh, G. Kosztolányi

Research output: Contribution to journalArticle

Abstract

INTRODUCTION: A clinical diagnosis of I-cell disease was established in an infant with coarse face, hyperplastic gums, severe growth deficiency, skeletal deformities and retarded psychomotor development. PATIENT/METHOD: Albeit, enzyme measurements in our patient leukocytes and serum including arylsulfatase, hexosaminidase, alpha-fucosidase, iduronate-sulphatase and beta-galactosidase showed no significant alteration, in serum an increased activity of beta-glucuronidase was detected. Enzyme studies in fibroblasts showed an abnormal intracellular/extracellular distribution of enzyme activities, and significantly decreased activity of UDP-N-acetylglucosamine-1-phosphotransferase confirming the diagnosis of I-cell disease. RESULTS/DISCUSSION: In the mother's next pregnancy at 15th week of gestation lysosomal enzyme activities were determined in amniotic fluid and cultured amniotic cells, and the diagnosis of an unaffected fetus was established. Based on our experience we suggest the use of cell cultures for the diagnostics of this rare disease.

Original languageHungarian
Pages (from-to)135-137
Number of pages3
JournalOrvosi Hetilap
Volume143
Issue number3
Publication statusPublished - Jan 20 2002

Fingerprint

Mucolipidoses
Enzymes
Iduronate Sulfatase
Uridine Diphosphate N-Acetylglucosamine
alpha-L-Fucosidase
Arylsulfatases
Hexosaminidases
Pregnancy
Glucuronidase
Gingiva
Amniotic Fluid
beta-Galactosidase
Rare Diseases
Serum
Cultured Cells
Fetus
Leukocytes
Cell Culture Techniques
Fibroblasts
Mothers

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Morava, E., Eduard, P., Tóth, G., Dobos, M., Melegh, B., & Kosztolányi, G. (2002). Mucolipidosis II. szokatlan biokémiai paraméterekkel. Orvosi Hetilap, 143(3), 135-137.

Mucolipidosis II. szokatlan biokémiai paraméterekkel. / Morava, Eva; Eduard, Paschke; Tóth, Gábor; Dobos, Matild; Melegh, B.; Kosztolányi, G.

In: Orvosi Hetilap, Vol. 143, No. 3, 20.01.2002, p. 135-137.

Research output: Contribution to journalArticle

Morava, E, Eduard, P, Tóth, G, Dobos, M, Melegh, B & Kosztolányi, G 2002, 'Mucolipidosis II. szokatlan biokémiai paraméterekkel.', Orvosi Hetilap, vol. 143, no. 3, pp. 135-137.
Morava E, Eduard P, Tóth G, Dobos M, Melegh B, Kosztolányi G. Mucolipidosis II. szokatlan biokémiai paraméterekkel. Orvosi Hetilap. 2002 Jan 20;143(3):135-137.
Morava, Eva ; Eduard, Paschke ; Tóth, Gábor ; Dobos, Matild ; Melegh, B. ; Kosztolányi, G. / Mucolipidosis II. szokatlan biokémiai paraméterekkel. In: Orvosi Hetilap. 2002 ; Vol. 143, No. 3. pp. 135-137.
@article{53d14b124dc8430f96f4a08de93c3943,
title = "Mucolipidosis II. szokatlan biok{\'e}miai param{\'e}terekkel.",
abstract = "INTRODUCTION: A clinical diagnosis of I-cell disease was established in an infant with coarse face, hyperplastic gums, severe growth deficiency, skeletal deformities and retarded psychomotor development. PATIENT/METHOD: Albeit, enzyme measurements in our patient leukocytes and serum including arylsulfatase, hexosaminidase, alpha-fucosidase, iduronate-sulphatase and beta-galactosidase showed no significant alteration, in serum an increased activity of beta-glucuronidase was detected. Enzyme studies in fibroblasts showed an abnormal intracellular/extracellular distribution of enzyme activities, and significantly decreased activity of UDP-N-acetylglucosamine-1-phosphotransferase confirming the diagnosis of I-cell disease. RESULTS/DISCUSSION: In the mother's next pregnancy at 15th week of gestation lysosomal enzyme activities were determined in amniotic fluid and cultured amniotic cells, and the diagnosis of an unaffected fetus was established. Based on our experience we suggest the use of cell cultures for the diagnostics of this rare disease.",
author = "Eva Morava and Paschke Eduard and G{\'a}bor T{\'o}th and Matild Dobos and B. Melegh and G. Kosztol{\'a}nyi",
year = "2002",
month = "1",
day = "20",
language = "Hungarian",
volume = "143",
pages = "135--137",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "3",

}

TY - JOUR

T1 - Mucolipidosis II. szokatlan biokémiai paraméterekkel.

AU - Morava, Eva

AU - Eduard, Paschke

AU - Tóth, Gábor

AU - Dobos, Matild

AU - Melegh, B.

AU - Kosztolányi, G.

PY - 2002/1/20

Y1 - 2002/1/20

N2 - INTRODUCTION: A clinical diagnosis of I-cell disease was established in an infant with coarse face, hyperplastic gums, severe growth deficiency, skeletal deformities and retarded psychomotor development. PATIENT/METHOD: Albeit, enzyme measurements in our patient leukocytes and serum including arylsulfatase, hexosaminidase, alpha-fucosidase, iduronate-sulphatase and beta-galactosidase showed no significant alteration, in serum an increased activity of beta-glucuronidase was detected. Enzyme studies in fibroblasts showed an abnormal intracellular/extracellular distribution of enzyme activities, and significantly decreased activity of UDP-N-acetylglucosamine-1-phosphotransferase confirming the diagnosis of I-cell disease. RESULTS/DISCUSSION: In the mother's next pregnancy at 15th week of gestation lysosomal enzyme activities were determined in amniotic fluid and cultured amniotic cells, and the diagnosis of an unaffected fetus was established. Based on our experience we suggest the use of cell cultures for the diagnostics of this rare disease.

AB - INTRODUCTION: A clinical diagnosis of I-cell disease was established in an infant with coarse face, hyperplastic gums, severe growth deficiency, skeletal deformities and retarded psychomotor development. PATIENT/METHOD: Albeit, enzyme measurements in our patient leukocytes and serum including arylsulfatase, hexosaminidase, alpha-fucosidase, iduronate-sulphatase and beta-galactosidase showed no significant alteration, in serum an increased activity of beta-glucuronidase was detected. Enzyme studies in fibroblasts showed an abnormal intracellular/extracellular distribution of enzyme activities, and significantly decreased activity of UDP-N-acetylglucosamine-1-phosphotransferase confirming the diagnosis of I-cell disease. RESULTS/DISCUSSION: In the mother's next pregnancy at 15th week of gestation lysosomal enzyme activities were determined in amniotic fluid and cultured amniotic cells, and the diagnosis of an unaffected fetus was established. Based on our experience we suggest the use of cell cultures for the diagnostics of this rare disease.

UR - http://www.scopus.com/inward/record.url?scp=0037138145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037138145&partnerID=8YFLogxK

M3 - Article

VL - 143

SP - 135

EP - 137

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 3

ER -